A detailed history of Sg3 Management, LLC transactions in Neuro Bo Pharmaceuticals, Inc. stock. As of the latest transaction made, Sg3 Management, LLC holds 50,000 shares of NRBO stock, worth $112,500. This represents 0.01% of its overall portfolio holdings.

Number of Shares
50,000
Holding current value
$112,500
% of portfolio
0.01%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form

About NeuroBo Pharmaceuticals, Inc.


  • Ticker NRBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 888,693
  • Market Cap $2M
  • Description
  • NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...
More about NRBO
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.